Lesch-Nyhan Syndrome: Models, Theories, and Therapies.

TitleLesch-Nyhan Syndrome: Models, Theories, and Therapies.
Publication TypeJournal Article
Year of Publication2016
AuthorsBell S, Kolobova I, Crapper L, Ernst C
JournalMol Syndromol
Volume7
Issue6
Pagination302-311
Date Published2016 Nov
ISSN1661-8769
Abstract

Lesch-Nyhan syndrome (LNS) is a rare X-linked disorder caused by mutations in HPRT1, an important enzyme in the purine salvage pathway. Symptoms of LNS include dystonia, gout, intellectual disability, and self-mutilation. Despite having been characterized over 50 years ago, it remains unclear precisely how deficits in hypoxanthine and guanine recycling can lead to such a profound neurological phenotype. Several studies have proposed different hypotheses regarding the etiology of this disease, and several treatments have been tried in patients, though none have led to a satisfactory explanation of the disease. New technologies such as next-generation sequencing, optogenetics, genome editing, and induced pluripotent stem cells provide a unique opportunity to map the precise sequential pathways leading from genotype to phenotype.

DOI10.1159/000449296
Alternate JournalMol Syndromol
PubMed ID27920633
PubMed Central IDPMC5131334

  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre